Actively Recruiting
Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial
Led by China Medical University Hospital · Updated on 2024-07-03
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of acupuncture as an additional treatment for patients with glaucoma. This randomized controlled trial involves 50 subjects diagnosed with mild to moderate primary open-angle glaucoma, aiming to assess the clinical effects of acupuncture over a 12-week observation period. The study seeks to provide useful information for future treatment guidelines for glaucoma patients. Participants will be randomly assigned to one of two groups the Ophthalmic Acupoint Treatment Group or the Non-ophthalmological Acupoint Control Group. Those in the treatment group will receive acupuncture at specific ophthalmology-related points designed to evoke the De Qi sensation, while the control group will get minimal acupuncture at different, non-ophthalmic points without this sensation. Both groups will have six weekly acupuncture sessions lasting 20 minutes each. During each visit, intraocular pressure, blood pressure, and heart rate will be measured. Before treatment and at 12 weeks, researchers will collect and analyze data including central corneal thickness, optical coherence tomography and angiography, visual field tests, and best-corrected visual acuity. Participants will also complete questionnaires assessing glaucoma symptoms and quality of life. The primary outcomes focus on changes in intraocular pressure throughout the treatment and observation periods.
CONDITIONS
Brief Title
Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with primary open angle glaucoma at least 3 months ago
- Mild or moderate open angle glaucoma diagnosis
- Using 1 or 2 types of glaucoma medications
- Age 20 years or older
- Signed informed consent and willing to cooperate with study procedures
You will not qualify if you...
- Received any ophthalmic laser or surgery within the past year
- Have high myopia
- Using any drugs that affect intraocular pressure
- Corrected visual acuity lower than 0.2
- Previous or current uveitis or retinopathy
- Unable to receive continuous acupuncture or allergic to acupuncture needles
- Pregnant or breastfeeding
- Refuse to sign the informed consent form
Research Team
L
LEE YU-CHEN, Ph.D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here